REFERENCES
- World Health Organization . 2009 . Global Tuberculosis Control: Surveillance, Planning, Financing , Geneva , Switzerland : WHO . WHO Report 2009Report No. WHO/HTM/TB/2009.411
- Centers for Disease Control and Prevention . 2010 . Updated guidelines for using Interferon Gamma Release assays to detect Mycobacterium tuberculosis infection, United States . MMWR Morb Mortal Wkly Rep. , 59 ( RR-5 ) : 1 – 26 . 2010
- Pai , M , Zwerling , A and Menzies , D . 2008 . Systematic review: T-cell–based assays for the diagnosis of latent tuberculosis infection: an update . Ann Intern Med. , 149 : 177 – 184 .
- Centers for Disease Control and Prevention . 1995 . Screening for tuberculosis and tuberculosis infection in high-risk populations: recommendations of the Advisory Council for the Elimination of Tuberculosis . MMWR Morb Mortal Wkly Rep. , 44 ( RR-11 ) : 18 – 34 .
- American Thoracic Society, Centers for Disease Control and Prevention . 2000 . Diagnostic standards and classification of tuberculosis in adults and children . Am J Respir Crit Care Med. , 161 : 1376 – 1395 .
- Veeser , P I , Smith , P K , Handy , B and Martin , S R . 2007 . Tuberculosis screening on a health science campus: use of QuantiFERON-TB Gold Test for students and employees . J Am Coll Health , 56 : 175 – 180 .
- Diel , R , Schaberg , T , Loddenkemper , R , Welte , T and Nienhaus , A . 2009 . Enhanced cost-benefit analysis of strategies for LTBI screening and INH chemoprevention in Germany . Respir Med. , 103 : 1838 – 1853 .
- Pooran , A , Booth , H Miller , R F . 2010 . Different screening strategies (single or dual) for the diagnosis of suspected latent tuberculosis: a cost effectiveness analysis . BMC Pulm Med. , 10 : 7